Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway
Pharmaceuticals · 16.09.2025 · 18 (9) · 1378
DOI: 10.3390/ph18091378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 16.09.2025. Verfasst von Lin Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizho…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Guizhou Provincial Science and Technology Basic Research Program, the Guizhou Provincial Science and Technology Innovation Talent Team Development Project.
Abstract (Originalsprache)
Background
Colon cancer is one of the most prevalent gastrointestinal malignancies worldwide, with high mortality and limited therapeutic options. Puerarin, a flavonoid compound derived from Pueraria lobata, has shown anticancer potential, but its molecular mechanisms against colon cancer remain unclear. Methods and Results: In this study, human colon cancer Caco-2 cells were treated with various concentrations of puerarin. Cell proliferation, migration, invasion, epithelial–mesenchymal transition (EMT), and apoptosis were evaluated using CCK-8, wound healing, Transwell, immunofluorescence, flow cytometry, and Western blot assays. Puerarin significantly inhibited Caco-2 cell proliferation in a dose- and time-dependent manner. It suppressed migration and invasion by increasing E-cadherin and reducing Vimentin expression. Apoptosis was induced via upregulation of BAX and downregulation of Bcl-2. Network pharmacology and KEGG analysis suggested PI3K/AKT signaling as a core regulatory pathway. Western blotting confirmed that puerarin reduced phosphorylation of PI3K and AKT. PI3K activator 740 Y-P promoted EMT and inhibited apoptosis, whereas puerarin and the PI3K inhibitor LY294002 reversed these effects.
Conclusions
Puerarin exerts significant antitumor effects on Caco-2 colon cancer cells by inhibiting proliferation, migration, and EMT, while promoting apoptosis. These effects are mediated primarily through suppression of the PI3K/AKT signaling pathway. This study provides a theoretical basis for the use of puerarin as a natural therapeutic agent in colon cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang…
- Key Laboratory of Natural Product Composition and Efficacy of Qiannan Prefecture, Qiannan Medical College for Nationalities, Duyun 558000, China.
- The High Efficacy Application of Natural Medicinal Resources Engineering Center of Guizhou Province, School of Pharmaceutical Sciences, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113…
- The Key Laboratory of Optimal Utilization of Natural Medicine Resources, School of Pharmaceutical Sciences, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113, China.
- Key Laboratory of Novel Anti-Cancer Drug Targets Discovery and Application, School of Pharmaceutical Sciences, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113, China.
ORCID-Profile: Xiangchun Shen
Förderung
- the National Natural Science Foundation of China
- the Guizhou Provincial Science and Technology Basic Research Program
- the Guizhou Provincial Science and Technology Innovation Talent Team Development Project
- the Program of the Guizhou Provincial Department of Science and Technology Project
- Additional support came from the Excellent Young Talents Plans of both Guizhou Province
- Guizhou Medical University (2020-101), and from key regional initiatives including the Guizhou Provincial Science and Technology Key Project
- the Guizhou Scientific and Technological Innovation Base
- the Key Laboratory Project of Guizhou Medical University
Zitieren
APA
Chen, L., Li, X., Zhao, S., Hao, M., Wang, H., Zhou, Z., Xiong, X., Yuan, D., Luo, P., Wang, L., Pan, D., Shen, X., Zhang, Y., & Chen, Y. (2025). Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway. Pharmaceuticals, 18(9), 1378. https://doi.org/10.3390/ph18091378
Vancouver
Chen L, Li X, Zhao S, Hao M, Wang H, Zhou Z, et al. Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway. Pharmaceuticals. 2025;18(9):1378. doi:10.3390/ph18091378
BibTeX
@article{Chen2025,
author = {Chen, Lin and Li, Xuhong and Zhao, Shijie and Hao, Mengyu and Wang, Heng and Zhou, Zhi and Xiong, Xinyu and Yuan, Die and Luo, Piao and Wang, Luwen and Pan, Di and Shen, Xiangchun and Zhang, Yue and Chen, Yan},
title = {Puerarin Inhibits Proliferation, Migration and Invasion of Colon Cancer Cells and Induces Apoptosis via Suppression of the PI3K/AKT Signaling Pathway},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {9},
pages = {1378},
doi = {10.3390/ph18091378}
}
EUVIMED